A feasibility study of the childhood depression medication algorithm: The Texas Children's Medication Algorithm Project (CMAP)

Graham J. Emslie, Carroll W. Hughes, M. Lynn Crismon, Molly Lopez, Steve Pliszka, Marcia G. Toprac, Christine Boemer

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective: To evaluate the feasibility and impact on clinical response and function associated with the use of an algorithm-driven disease management program (ALGO) for children and adolescents treated for depression with or without attention-deficit/hyperactivity disorder (ADHD) in community mental health centers. Method: Interventions included (1) medication algorithms, (2) clinical and technical support for the physician, (3) uniform chart documentation of outcomes, and (4) a patient/family psychoeducation program. Children eligible for entry into the study were referred to the child psychiatrist for initiation or change in medicine. Outcomes of treatment with the ALGO for up to 4 months are presented. Measures of change included clinical symptoms, functioning, and global improvement (Clinical Global Impression Scale). A historical chart cohort from the same clinics was used as a quasi-control. Results: Thirty-nine individuals (depression = 24; comorbid depression with ADHD = 15) were enrolled for treatment with ALGO. One hundred fourteen children were in the control cohort (74 depressed, 40 comorbid). For the ALGO groups, Children's Depression Rating Scale-Revised depression severity scores decreased from 48.2 to 32.5 and Child Adolescent Functioning Assessment Scale function scores improved from 70.3 to 40.9 (all p ≤ .0005). Clinical Global Impression Scale severity scores decreased from 5.7 to 3.7 in ALGO compared to only 5.8 to 4.8 in the control (p < .003). Conclusions: There was clear improvement in clinical symptoms, functioning, and global response with ALGO treatment. The magnitude of the improvement was greater in children and adolescents treated with the ALGO program compared with a historical cohort. These data support the need for controlled studies in larger populations examining the effects of algorithm-driven disease management programs on the clinical outcomes of children with mental illness.

Original languageEnglish (US)
Pages (from-to)519-527
Number of pages9
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume43
Issue number5
DOIs
StatePublished - May 2004

Fingerprint

Feasibility Studies
Depression
Attention Deficit Disorder with Hyperactivity
Disease Management
Community Mental Health Centers
Documentation
Psychiatry
Medicine
Physicians
Therapeutics
Population

Keywords

  • Child and adolescent depression
  • Childhood disorders
  • Childhood psychopharmacology
  • Comorbid attention deficit/hyperactivity disorder and major depressive disorder
  • Medication algorithm

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

A feasibility study of the childhood depression medication algorithm : The Texas Children's Medication Algorithm Project (CMAP). / Emslie, Graham J.; Hughes, Carroll W.; Crismon, M. Lynn; Lopez, Molly; Pliszka, Steve; Toprac, Marcia G.; Boemer, Christine.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 43, No. 5, 05.2004, p. 519-527.

Research output: Contribution to journalArticle

Emslie, Graham J. ; Hughes, Carroll W. ; Crismon, M. Lynn ; Lopez, Molly ; Pliszka, Steve ; Toprac, Marcia G. ; Boemer, Christine. / A feasibility study of the childhood depression medication algorithm : The Texas Children's Medication Algorithm Project (CMAP). In: Journal of the American Academy of Child and Adolescent Psychiatry. 2004 ; Vol. 43, No. 5. pp. 519-527.
@article{a4820077ebdd4581b13ce4c16fe8b1dd,
title = "A feasibility study of the childhood depression medication algorithm: The Texas Children's Medication Algorithm Project (CMAP)",
abstract = "Objective: To evaluate the feasibility and impact on clinical response and function associated with the use of an algorithm-driven disease management program (ALGO) for children and adolescents treated for depression with or without attention-deficit/hyperactivity disorder (ADHD) in community mental health centers. Method: Interventions included (1) medication algorithms, (2) clinical and technical support for the physician, (3) uniform chart documentation of outcomes, and (4) a patient/family psychoeducation program. Children eligible for entry into the study were referred to the child psychiatrist for initiation or change in medicine. Outcomes of treatment with the ALGO for up to 4 months are presented. Measures of change included clinical symptoms, functioning, and global improvement (Clinical Global Impression Scale). A historical chart cohort from the same clinics was used as a quasi-control. Results: Thirty-nine individuals (depression = 24; comorbid depression with ADHD = 15) were enrolled for treatment with ALGO. One hundred fourteen children were in the control cohort (74 depressed, 40 comorbid). For the ALGO groups, Children's Depression Rating Scale-Revised depression severity scores decreased from 48.2 to 32.5 and Child Adolescent Functioning Assessment Scale function scores improved from 70.3 to 40.9 (all p ≤ .0005). Clinical Global Impression Scale severity scores decreased from 5.7 to 3.7 in ALGO compared to only 5.8 to 4.8 in the control (p < .003). Conclusions: There was clear improvement in clinical symptoms, functioning, and global response with ALGO treatment. The magnitude of the improvement was greater in children and adolescents treated with the ALGO program compared with a historical cohort. These data support the need for controlled studies in larger populations examining the effects of algorithm-driven disease management programs on the clinical outcomes of children with mental illness.",
keywords = "Child and adolescent depression, Childhood disorders, Childhood psychopharmacology, Comorbid attention deficit/hyperactivity disorder and major depressive disorder, Medication algorithm",
author = "Emslie, {Graham J.} and Hughes, {Carroll W.} and Crismon, {M. Lynn} and Molly Lopez and Steve Pliszka and Toprac, {Marcia G.} and Christine Boemer",
year = "2004",
month = "5",
doi = "10.1097/00004583-200405000-00005",
language = "English (US)",
volume = "43",
pages = "519--527",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - A feasibility study of the childhood depression medication algorithm

T2 - The Texas Children's Medication Algorithm Project (CMAP)

AU - Emslie, Graham J.

AU - Hughes, Carroll W.

AU - Crismon, M. Lynn

AU - Lopez, Molly

AU - Pliszka, Steve

AU - Toprac, Marcia G.

AU - Boemer, Christine

PY - 2004/5

Y1 - 2004/5

N2 - Objective: To evaluate the feasibility and impact on clinical response and function associated with the use of an algorithm-driven disease management program (ALGO) for children and adolescents treated for depression with or without attention-deficit/hyperactivity disorder (ADHD) in community mental health centers. Method: Interventions included (1) medication algorithms, (2) clinical and technical support for the physician, (3) uniform chart documentation of outcomes, and (4) a patient/family psychoeducation program. Children eligible for entry into the study were referred to the child psychiatrist for initiation or change in medicine. Outcomes of treatment with the ALGO for up to 4 months are presented. Measures of change included clinical symptoms, functioning, and global improvement (Clinical Global Impression Scale). A historical chart cohort from the same clinics was used as a quasi-control. Results: Thirty-nine individuals (depression = 24; comorbid depression with ADHD = 15) were enrolled for treatment with ALGO. One hundred fourteen children were in the control cohort (74 depressed, 40 comorbid). For the ALGO groups, Children's Depression Rating Scale-Revised depression severity scores decreased from 48.2 to 32.5 and Child Adolescent Functioning Assessment Scale function scores improved from 70.3 to 40.9 (all p ≤ .0005). Clinical Global Impression Scale severity scores decreased from 5.7 to 3.7 in ALGO compared to only 5.8 to 4.8 in the control (p < .003). Conclusions: There was clear improvement in clinical symptoms, functioning, and global response with ALGO treatment. The magnitude of the improvement was greater in children and adolescents treated with the ALGO program compared with a historical cohort. These data support the need for controlled studies in larger populations examining the effects of algorithm-driven disease management programs on the clinical outcomes of children with mental illness.

AB - Objective: To evaluate the feasibility and impact on clinical response and function associated with the use of an algorithm-driven disease management program (ALGO) for children and adolescents treated for depression with or without attention-deficit/hyperactivity disorder (ADHD) in community mental health centers. Method: Interventions included (1) medication algorithms, (2) clinical and technical support for the physician, (3) uniform chart documentation of outcomes, and (4) a patient/family psychoeducation program. Children eligible for entry into the study were referred to the child psychiatrist for initiation or change in medicine. Outcomes of treatment with the ALGO for up to 4 months are presented. Measures of change included clinical symptoms, functioning, and global improvement (Clinical Global Impression Scale). A historical chart cohort from the same clinics was used as a quasi-control. Results: Thirty-nine individuals (depression = 24; comorbid depression with ADHD = 15) were enrolled for treatment with ALGO. One hundred fourteen children were in the control cohort (74 depressed, 40 comorbid). For the ALGO groups, Children's Depression Rating Scale-Revised depression severity scores decreased from 48.2 to 32.5 and Child Adolescent Functioning Assessment Scale function scores improved from 70.3 to 40.9 (all p ≤ .0005). Clinical Global Impression Scale severity scores decreased from 5.7 to 3.7 in ALGO compared to only 5.8 to 4.8 in the control (p < .003). Conclusions: There was clear improvement in clinical symptoms, functioning, and global response with ALGO treatment. The magnitude of the improvement was greater in children and adolescents treated with the ALGO program compared with a historical cohort. These data support the need for controlled studies in larger populations examining the effects of algorithm-driven disease management programs on the clinical outcomes of children with mental illness.

KW - Child and adolescent depression

KW - Childhood disorders

KW - Childhood psychopharmacology

KW - Comorbid attention deficit/hyperactivity disorder and major depressive disorder

KW - Medication algorithm

UR - http://www.scopus.com/inward/record.url?scp=2642517153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2642517153&partnerID=8YFLogxK

U2 - 10.1097/00004583-200405000-00005

DO - 10.1097/00004583-200405000-00005

M3 - Article

C2 - 15100558

AN - SCOPUS:2642517153

VL - 43

SP - 519

EP - 527

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 5

ER -